Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Non-obese women with hair loss have higher heart disease risk.

Young women with PCOS without additional risk factors may have normal heart function.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.